News | Cardiac Imaging | February 28, 2024

Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients

New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases

New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases

February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image Guided Therapy System – Azurion – with the launch of its new Azurion neuro biplane system. Designed to improve productivity and help care teams make the right decisions faster, treat more patients, and achieve better outcomes, the new interventional system features enhanced 2D and 3D imaging and X-ray detector positioning flexibility.

Minimally invasive procedures are a key part of the diagnosis and treatment pathway for stroke, where every minute counts in conserving the patient’s quality-of-life. Interventional systems are also used to precisely plan and carry out complex neurovascular procedures such as the repair of brain aneurysms and birth defects. By allowing neuro interventionists to treat more patients, more efficiently, with potentially better outcomes, the new Philips Azurion neuro biplane system enhances both the staff and patient experience and contributes to lower cost of care.

“Working closely with leading interventionists, we designed the latest Azurion neuro biplane to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment,” said Mark Stoffels, Business Leader of Image Guided Therapy Systems at Philips. “Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health.”

Philips’ Azurion neuro biplane image-guided therapy system is designed to smooth and optimize procedure workflows where a combination of 2D and 3D imaging is needed for confident diagnosis and precision treatment. Used with the company’s latest Neuro Suite software and services, itprovides neuro interventionists with a fully integrated solution that combines Philips’ world-class ClarityIQ low dose imaging with a range of neuro dedicated tools* and value-added services that offer unprecedented levels of efficiency, flexibility, and control.

New features in the Azurion neuro biplane system include enhanced C-arm rotation, angulation (imaging angles), and parking facilities that allow rapid transitioning between 2D to 3D imaging, comprehensive table-side control that eliminates the need to leave the sterile field, automatic beam rotation to obtain correctly oriented images for every angulation and rotation, and a new head immobilizer to support enhanced stroke care. 

 

Accelerating treatment for stroke

One in four adults over the age of 25 will have a stroke at some point in their lives [1]. Globally, the direct and indirect cost has been estimated at around USD 891 billion per year [2]. The key to reducing the personal, societal, and financial impact of stroke is to follow the axiom ‘time-is-brain’. The faster stroke is treated, the better the potential outcome.

For ischemic stroke, which accounts for 87% of all strokes [3], the benefits of delivering intra-arterial treatment (IAT) – catheter-based procedures to mechanically disrupt or remove blood clots (mechanical thrombectomy) and/or inject clot-busting agents – within 6 hours of symptom onset, are widely accepted [4]. With mechanical thrombectomy becoming the standard for treating large vessel occlusion (LVO) ischemic stroke, the demand for high utilization angio suites that allow interventionists to operate with speed and efficiency has rapidly increased.

In addition to the efficiency enhancing features of its Azurion platform, Philips is maximizing the up-time of its angio suite solutions by using AI and machine learning to monitor system performance through the new remote connection services of the Philips ServiceHub. These services communicate, monitor, and proactively respond to potential service issues – for example, predicting likely component failures at least 7 days in advance so that pre-emptive action can be taken.

With its comprehensive stroke care portfolio, Philips is connecting the dots between caregivers – wherever they are – at every vital step in the stroke care pathway. The result is smart stroke solutions designed to support connected care.

For more information: www.philips.com

 

References:

*SmartCT Soft Tissue, SmartCT Angio, SmartCT Roadmap, SmartCT Vaso, AneurysmFlow 
[1] World Stroke Organization (WSO): Global Stroke Fact Sheet 2022 (https://www.world-stroke.org/assets/downloads/WSO_Global_Stroke_Fact_Sheet.pdf)

[2] Owolabi MO, Thrift AG, Mahal A, et al.; Stroke Experts Collaboration Group. Primary stroke prevention worldwide: translating evidence into action. Lancet Public Health. 2022 Jan;7(1):e74-e85. doi: 10.1016/S2468-2667(21)00230-9. Epub 2021 Oct 29. Erratum in: Lancet Public Health. 2022 Jan;7(1):e14. PMID: 34756176; PMCID: PMC8727355. https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(21)00230-9/fulltext

[3] Virani S.S., Alonso A., Benjamin E.J., et al. Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. https://www.ahajournals.org/doi/full/10.1161/CIR.0000000000000757?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org

[4] NHS England UK : https://www.england.nhs.uk/wp-content/uploads/2019/05/Mechanical-thrombectomy-for-acute-ischaemic-stroke-ERRATA-29-05-19.pdf

[5] WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment). Sponsored by Philips. https://www.wetrust-study.com/

 

Find more ECR24 conference coverage here


Related Content

News | Cardiac Imaging

Cleerly, a leader in cardiovascular imaging, today announced the promotions of two key executives to expanded leadership ...

Home July 02, 2025
Home
News | Cardiac Imaging

June 25, 2025 — Royal Philips and Methodist Hospitals recently announced the healthcare provider’s strategic investment ...

Home June 25, 2025
Home
News | Cardiac Imaging

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Home June 12, 2025
Home
News | Cardiac Imaging

April 1, 2025 — UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual ...

Home April 15, 2025
Home
News | Cardiac Imaging

April 3, 2025 — Tower Health and Siemens Healthineers recently announced a 10-year agreement focused on equipment ...

Home April 04, 2025
Home
News | Cardiac Imaging

Pfizer has awarded $80,000 to Rutgers Robert Wood Johnson Medical School (RWJMS) to fund an Amyloidosis Fellowship at ...

Home December 19, 2024
Home
News | Cardiac Imaging

Dec. 11, 2024 — Genetesis, Inc. has launched the CardioFlux Membership program. CardioFlux Membership is designed to be ...

Home December 18, 2024
Home
News | Cardiac Imaging

Nov. 13, 2024 – A recent study has demonstrated the value of the single-exposure dual-energy X-ray detector in advancing ...

Home November 13, 2024
Home
News | Cardiac Imaging

Oct. 15, 2024 — Four of the seven Medicare Administrative Contractors (MACs) have released final local coverage ...

Home October 16, 2024
Home
News | Cardiac Imaging

Oct. 15, 2024 – Elucid has announced that four of the seven Medicare Administrative Contractors (MACs) will extend ...

Home October 15, 2024
Home
Subscribe Now